The German Version of the Behavioral Activation for Depression Scale (BADS): A Psychometric and Clinical Investigation

Teismann, Tobias; Ertle, Andrea; Furka, Nadine; Willutzki, Ulrike; Hoyer, Jana

doi:10.1002/cpp.1948

Cited by 31 publications

(24 citation statements)

References 32 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…(17) BAS, the assessment instrument of behavioral activation, was generated through an exploratory factor analysis of a rationally derived set of items followed by a confirmatory factor analysis. (17, 18) This factor structure was replicated in community samples with elevated depressive symptoms (19, 20) and in depressed outpatients (21). Adequate reliability and validity were reported for the BAS in all the above studies, with BAS scores showing predicted associations with depressive symptoms.…”

Section: Methodsmentioning

confidence: 72%

See 1 more Smart Citation

“Engage” Therapy: Behavioral Activation and Improvement of Late-Life Major Depression

Alexopoulos

Raue

Gunning

et al. 2016

The American Journal of Geriatric Psychiatry

View full text Add to dashboard Cite

Objective Engage is a treatment for late-life depression developed to match the skills of community clinicians. It is based on the theory that dysfunction in the RDoC positive valence systems (PVS) is a critical mechanism of late life depression. Accordingly, it uses “reward exposure” (engagement in meaningful, rewarding activities) as its principal intervention. This study tests the hypothesis that change in behavioral activation, an index of PVS function, during successive treatment periods with Engage and during follow-up predicts depression at the end of each period. Methods Forty-eight non-demented, older adults with unipolar major depression were treated openly with 9 weekly sessions of Engage and assessed 36 weeks after entry. Depression severity was assessed with the 24-item Hamilton Depression Rating Scale (HAM-D) and behavioral activation with the Behavioral Activation for Depression Scale (BAS) at baseline, 6 weeks (mid-treatment), 9 weeks (end of treatment), and 36 weeks. Results A mixed effects model examined whether change in BAS in successive periods occurring during Engage treatment and during follow-up predicts depression at the end of each period. Both BAS change (F1, 52=18.63, p<0.0001) and time (F2, 52=7.68, p=0.0012) predicted HAM-D scores at the end of each observation period. For every point of increase in BAS change, there was a reduction of HAM-D by 0.105 points. HAM-D at each point did not predict subsequent change in BAS (F1, 52=2.17, p = 0.146). Conclusion During Engage treatment and follow-up, change in behavioral activation is followed by improvement of depressive symptoms and signs.

show abstract

Section: Methodsmentioning

confidence: 72%

“…While overlap cannot be excluded, the BAS explained only 18.4% of the variance in depressive symptomatology in depressed outpatients. (21)…”

Section: Discussionmentioning

confidence: 99%

“Engage” Therapy: Behavioral Activation and Improvement of Late-Life Major Depression

Alexopoulos

Raue

Gunning

et al. 2016

The American Journal of Geriatric Psychiatry

View full text Add to dashboard Cite

show abstract

“…In order to provide repeated measures of potential mechanisms of change, at the beginning of each training session, participants will make a series of ratings about their mood and cognition over the previous day. Participants will rate the mood words: happy, sad, calm, anxious, optimistic, hopeless, and the following statements “Positive thoughts seem to pop into my head,” “Negative thoughts seem to pop into my head,” “I have been able to look forward to activities and events,” “I have been able to enjoy taking part in activities or events,” “I was an active person and accomplished the goals I set out to do.” (this last item taken from the Behavioral Activation for Depression Scale [ 73 ], German version by [ 74 ]). Ratings are made on the scale used for the PANAS (i.e., from 1 = not at all to 5 = extremely).…”

Section: Methodsmentioning

confidence: 99%

Computerized positive mental imagery training versus cognitive control training versus treatment as usual in inpatient mental health settings: study protocol for a randomized controlled feasibility trial

Blackwell

Westermann

Woud

et al. 2018

Pilot Feasibility Stud

View full text Add to dashboard Cite

BackgroundEnhancing the capacity to experience positive affect could help improve recovery across a range of areas of mental health. Experimental psychopathology research indicates that a computerized cognitive training paradigm involving generation of positive mental imagery can increase state positive affect, and more recent clinical studies have suggested that this training could be used as an adjunct treatment module to target symptoms related to positive affect deficits, specifically anhedonia. The current study investigates the feasibility of adding a positive mental imagery computerized training module to treatment for patients in inpatient mental health settings, with a focus on increasing positive affect and reducing anhedonia. The positive mental imagery training (PMIT) is added to treatment as usual (TAU) in the inpatient setting, and compared to TAU alone, or TAU plus an alternative cognitive training module not hypothesized to increase positive affect, cognitive control training (CCT).MethodsThe study is a feasibility randomized controlled trial with three parallel arms. Up to 90 patients admitted to inpatient mental health treatment clinics in Germany will be randomized to PMIT + TAU, CCT + TAU, or TAU on a 1:1:1 ratio. PMIT or CCT consist of an introductory session followed by up to 8 full training sessions over 2 weeks. All three arms (including TAU) include regular completion of mood measures over the 2-week period. Outcome measures are completed pre and post this 2-week training/monitoring period, and at 2-week follow-up. Data will be presented in the form of both raw means and standardized effect sizes, with 95% confidence intervals, for both intention-to-treat and per-protocol samples.DiscussionThe study will inform feasibility of conducting a fully powered randomized controlled trial investigating the addition of the positive mental imagery training as a treatment adjunct to inpatient treatments for mental health, including potential refinement of study procedures, inclusion/exclusion criteria, and preliminary indications of the likely range of effect sizes.Trial registrationclinicaltrials.gov, NCT02958228 (date registered: 4 November 2016)

show abstract

“…Behavioural activation The Behavioral Activation for Depression Scale (BADS) [72] examines the role of controlling aversive stimuli and avoidance behaviour in depression. As such, it observes changes in activation within treatment.…”

Section: Secondary Outcomesmentioning

confidence: 99%

Effectiveness and cost-effectiveness of guided Internet- and mobile-based CBT for adolescents and young adults with chronic somatic conditions and comorbid depression and anxiety symptoms (youthCOACHCD): study protocol for a multicentre randomized controlled trial

Lunkenheimer¹,

Domhardt²,

Geirhos³

et al. 2020

Trials

View full text Add to dashboard Cite

Background: Adolescents and young adults (AYA) with chronic somatic conditions have an increased risk of comorbid depression and anxiety symptoms. Internet-and mobile-based cognitive behavioural therapy (iCBT) might be one possibility to extend the access to evidence-based treatments. Studies suggest that guided iCBT can reduce anxiety and depression symptoms in AYA. However, little is known about the effectiveness of iCBT for AYA with chronic somatic conditions and comorbid symptoms of anxiety and/or depression in routine care. Evidence on the (cost-)effectiveness of iCBT is essential for its implementation in health care. Objectives and methods: This multicentre two-armed randomized controlled trial (RCT) aims to evaluate the (cost-) effectiveness of guided iCBT (youthCOACH CD) in addition to treatment as usual (TAU) compared to enhanced treatment as usual (TAU+) in AYA aged 12-21 years with one of three chronic somatic conditions (type 1 diabetes, cystic fibrosis, or juvenile idiopathic arthritis). AYA with one of the chronic somatic conditions and elevated symptoms of anxiety or depression (Patient Health Questionnaire [PHQ-9] and/or Generalized Anxiety Disorder [GAD-7] Screener score ≥ 7) will be eligible for inclusion. We will recruit 212 patients (2 × n = 106) in routine care through three German patient registries. Assessments will take place at baseline and at 6 weeks, 3 months, 6 months, and 12 months postrandomization. The primary outcome will be combined depression and anxiety symptom severity as measured with the PHQ Anxiety and Depression Scale. Secondary outcomes will include health-related quality of life, coping strategies, self-efficacy, stress-related personal growth, social support, behavioural activation, adjustment and trauma-related symptoms, automatic thoughts, intervention satisfaction, working alliance, and Internet usage. The cost-effectiveness will be determined, and potential moderators and mediators of intervention effects will be explored.

show abstract

The German Version of the Behavioral Activation for Depression Scale (BADS): A Psychometric and Clinical Investigation

Cited by 31 publications

References 32 publications

“Engage” Therapy: Behavioral Activation and Improvement of Late-Life Major Depression

“Engage” Therapy: Behavioral Activation and Improvement of Late-Life Major Depression

Computerized positive mental imagery training versus cognitive control training versus treatment as usual in inpatient mental health settings: study protocol for a randomized controlled feasibility trial

Effectiveness and cost-effectiveness of guided Internet- and mobile-based CBT for adolescents and young adults with chronic somatic conditions and comorbid depression and anxiety symptoms (youthCOACHCD): study protocol for a multicentre randomized controlled trial

Contact Info

Product

Resources

About